Onureg

Active Ingredient(s): Azacitidine
FDA Approved: * September 1, 2020
Pharm Company: * CELGENE CORP
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Onureg Overview

Azacitidine (INN; trade name Vidaza) is a chemical analog of cytidine, a nucleoside in DNA and RNA. Azacitidine and its deoxy derivative, decitabine (also known as 5-aza-2′-deoxycytidine), are used in the treatment of myelodysplastic syndrome. Both drugs were first synthesized in Czechoslovakia as potential chemotherapeutic agents for cancer.[3] Contents 1 Uses 1.1 Clinical 1.2 Non-clinical 2 Mechanism of action 2.1 Inhibition of methylation 3 Toxicity 4 See als...

Read more Onureg Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Azacitidine

Recent Onureg Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Azacitidine
  • Injection: 100mg, 100mg/vial
  • Powder: 100mg/vial
  • Tablet: 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Azacitidine or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 28 September 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA